Zhivka Stoykova

Zhivka Stoykova

Auto-generated profile, based on publicly available information

Zhivka Stoykova

Med Univ Varna, Dept Microbiol & Virol, Varna, Bulgaria

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in Journal of Drug Assessment
Verified
Journal Article
Open access
ZBZarina Brady
Zarina Brady
ZSZhivka Stoykova
Zhivka Stoykova
Background: The main objective of this study was to analyse the spread of hepatitis C virus (HCV) genotype in patients with chronic liver disease; commenting on the molecular characterization of HCV and gender and age in Varna, Bulgaria. Across Europe and the world, HCV is a significant economic concern and public health crisis. Defined by genotype variations, HCV is the leading cause of chronic liver disease, liver related morbidity, and mortality worldwide. Active examination for asymptomatic patients is essential, initiating early treatment aimed at the specific HCV genotype, effective outcomes, and reducing transmission and mortality in Bulgaria. Methods and materials: Nucleic acid extraction and amplification were performed with commercially available test kits on 115 patients blood samples collected from March 2018 to October 2018. Male (n = 58) (50.43%, 95% CI = 41.29%–59.57%) and female (n = 57) (49.57%, 95% CI = 41.29%–59.57%) samples were equally distributed (mean age = 51.4 years; SD = ±16.5 years; range = 17–87 years old). Results: Genotype 1b predominated (73%, 95% CI = 64.89%–81.11%), followed by high prevalence of 1a (13.9%, 95% CI = 7.58%–20.22%) and 3 genotypes (11.3%, 95% CI = 5.51%–17.09%). Genotypes 2 and 4 were equally the least prevalent (0.9%, 95% CI = −0.83%–2.63%). In genotype 1b, 60.7% were women and 39.3% were men; in genotype 1a, 25% were women and 75% were men; and in genotype 3, only 7.7% were women and 92.3% were men. Males were most prevalent in genotypes 1a (75%) and 3 (92.3%), while women were most prevalent in genotype 1b (60.7%). Conclusions: HCV genotype lb is the predominant variant within the epidemiological pattern of HCV genotypes in patients with chronic liver diseases in North Eastern Bulgaria.

18 November 2015
Verified
Book Chapter
Open access
PDF file
LILiliya Ivanova
Liliya Ivanova
DTDenitza Tsaneva
Denitza Tsaneva
ZSZhivka Stoykova
Zhivka Stoykova
TKTcvetelina Kostadinova
Tcvetelina Kostadinova
Viral Diseases in Transplant and Immunocompromised Patients | InTechOpen, Published on: 2015-11-18. Authors: Liliya Ivanova, Denitza Tsaneva, Zhivka Stoykova, et

1 January 2021 in Biotechnology & Biotechnological Equipment
Verified
Journal Article
Open access
TKTsvetelina Kostadinova
Tsvetelina Kostadinova
TTTatina Todorova
Tatina Todorova
ZSZhivka Stoykova
Zhivka Stoykova
DNDenis Niyazi
Denis Niyazi
MBMilena Bozhkova
Milena Bozhkova
TSTemenuga Stoeva
Temenuga Stoeva
The SARS-CoV-2 pandemic is the most devastating health crisis our generation has seen. The present study tries to gather more epidemiological data and improve the knowledge of the demographic factors responsible for a higher incidence of COVID-19. We analyzed the real time polymerase chain reaction (RT-PCR) results obtained in one of the biggest tertiary hospitals in Bulgaria during the first year of the COVID-19 pandemic (May 2020–April 2021). For this period, almost 40% of all tested samples of hospitalized patients and health care workers in University Hospital “St. Marina,” Varna, were SARS-CoV-2 positive. The most affected individuals were 60–79-year-old people. Male sex is a significant risk factor only for the active ages (20–59 years), while both men and women of advanced age have the same risk to be infected with SARS-CoV-2. Interestingly, girls under 19 years were more susceptible to the infection than boys in the same age group.

1 September 2017 in Folia Medica
Verified
Journal Article
Open access
PDF file
ZSZhivka D. Stoykova
Zhivka D. Stoykova
LILilia I. Ivanova
Lilia I. Ivanova
TTTatina T. Todorova
Tatina T. Todorova
Background:Human cytomegalovirus is a ubiquitous, large enveloped DNA β-herpesvirus that, like other herpesviruses, establishes lifelong latency following primary infection. It is the most frequent cause of congenital, neonatal and early postnatal infections with long lasting sequelae.Aim:The aim of the present study was to assess the prevalence of cytomegalovirus among a cohort of newborns and 1-3-month-old children with neurological symptoms, physical retardation, prolonged jaundice, thrombocytopenic purpura and other disabilities.Materials and methods:The study was a retrospective cross-sectional analysis of serological screening data for detection of specific anti-cytomegalovirus IgM and IgG in children from Northeastern Bulgaria.Results:Between 2003 and 2015, average prevalences of 18.8% (95% CI: 15.4 to 22.2) for anti-CMV IgM antibodies (suggesting acute infection) and 84.7% (95% CI: 81.6 to 87.8) for anti-CMV IgG antibodies were measured in a total number of 517 samples. The prevalence rate of anti-CMV IgM in 1-3-month-old children was 4-fold higher than that in newborns [25.8% (95% CI: 21.1 to 30.5) and 6.4% (95% CI: 2.9 to 9.9, respectively]. In contrast, no significant difference was found for anti- CMV IgG positivity between newborns and 1-3-month-old infants (84% and 85%, respectively).Conclusions:The data obtained strongly encourage screening of pregnant women for anti-CMV IgG and IgM to avoid transmission of the infection and severe complications of congenital infection.

31 January 2019 in Indian Journal of Hematology and Blood Transfusion
Verified
Journal Article
Open access
PDF file
TKTsvetelina Kostadinova
Tsvetelina Kostadinova
LILiliya Ivanova Ivanova
Liliya Ivanova Ivanova
TTTatina Todorova Todorova
Tatina Todorova Todorova
ZSZhivka Stoykova
Zhivka Stoykova
DSDobromir Staykov
Dobromir Staykov
LGLiana Gercheva
Liana Gercheva
Epstein–Barr virus is the first human oncogenic virus associated with a broad range of different malignant diseases but its role in non-Hodgkin lymphomas (NHL) development still needs to be fully understood. High expression levels of EBV major genes are found in NHL tumor cells and free viral DNA circulates in the plasma of such individuals. In the current study we detected EBV DNA levels in plasma samples from NHL patients in order to validate its significance as a laboratory marker for disease monitoring. We investigated a cohort of 52 patients diagnosed with NHL in The University Hospital “St. Marina” Varna, Bulgaria. Viral DNA was extracted from single plasma samples using Kit Ribo Virus (Sacace Biotechnologies S.r.l., Como, Italy) and amplified with EBV Real-TM Quant (Sacace Biotechnologies S.r.l., Como, Italy). Plasma samples of the same patients were tested for presence of EBV VCA IgM/IgG antibodies with indirect ELISA tests (Euroimmun, Luebeck, Germany). We found 15.4% (95% CI 6.9–28.1%, n = 8) of the samples from NHL patients to be positive in quantitative PCR (range 674–221,333 copies/ml). The diffuse large B cell lymphomas and peripheral T cell lymphomas were most often associated (although not statistically significant, p = 0.167) with detectable plasma EBV DNA levels. To our knowledge, this is the first study about the role of EBV in NHL development in Bulgaria. The results we have obtained should stimulate new, larger investigations to apply the quantitative PCR technique in the routine laboratory EBV diagnosis.

15 October 2018 in Journal of IMAB – Annual Proceeding (Scientific Papers)
Verified
Journal Article
Open access
DTDenitsa Tsaneva-Damyanova
Denitsa Tsaneva-Damyanova
EGElitsa Golkocheva-Markova
Elitsa Golkocheva-Markova
NVNational Centre Of Infectious And Parasitic Diseases Nrl Hepatitis Viruses
National Centre Of Infectious And Parasitic Diseases Nrl Hepatitis Viruses
LILiliya Ivanova
Liliya Ivanova
TKTsvetelina Kostadinova
Tsvetelina Kostadinova
ZSZhivka Stoykova
Zhivka Stoykova